Drug firm Alkem Laboratories Friday reported a 13.58 per cent rise in its consolidated net profit to Rs 205.45 crore for the quarter ended December 31, 2018.
The company had posted a net profit of Rs 180.87 crore for the corresponding period of the previous fiscal, Alkem Laboratories said in a filing to BSE.
Consolidated revenue from operations of the company stood at Rs 1,925.03 crore for the quarter under consideration as against Rs 1,741.19 crore for the same period a year ago.
The company's board has declared an interim dividend of Rs 8 per equity share of the face value of 2 each, Alkem Laboratories said.
Shares of the company were trading at Rs 1,893.50 per scrip on BSE, up 0.57 per cent from its previous close.
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)